WASHINGTON, June 17 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration has established a Class II regulatory classification for ingestible gastrointestinal blood detection capsules, creating a pathway for devices that detect blood within the digestive tract to enter the market under special controls rather than the more stringent Class III framework.

FDA said the device is a prescription-only capsule that uses spectrophotometry, or light absorpt . . .

Click here for more information about our products